Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials.

Keogh, Ruth H; Cosgriff, Rebecca; Andrinopoulou, Eleni-Rosalina; Brownlee, Keith G; Carr, Siobhán B; Diaz-Ordaz, Karla; Granger, Emily; Jewell, Nicholas P; Lewin, Alex; Leyrat, Clemence; +4 more... Schlüter, Daniela K; van Smeden, Maarten; Szczesniak, Rhonda D; Connett, Gary J; (2021) Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials. Thorax. ISSN 0040-6376 DOI: https://doi.org/10.1136/thoraxjnl-2020-216265

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1136/thoraxjnl-2020-216265

Abstract

Item Type Article
Faculty and Department Faculty of Epidemiology and Population Health > Dept of Medical Statistics
PubMed ID 34556554
Elements ID 166318

Share

Download

Filename: Keogh_etal_2021_Projecting-the-impact-of-triple.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar